World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October...
from NDTV News - Special https://ift.tt/39g9eSN
via IFTTT
0 Comments